Xu et al found that bifunctional liposomes loaded with hypoxia‐inducible factor‐1(HIF‐1) inhibitors, acriflavine (ACF), and DOX (DOX‐ACF@Lipo) can reduce the chemoresistance to DOX in advanced CRC.130. This evidence concerns the gene HIF1A and colorectal carcinoma.